Greg Harrison
Stock Analyst at Scotiabank
(0)
# 4249
Out of 5,329 analysts
85
Total ratings
39.29%
Success rate
-11.03%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BBIO BridgeBio Pharma | Maintains: Sector Outperform | 52 55 | 38.51 | 42.82% | 6 | Apr 30, 2025 | |
UTHR United Therapeutics | Upgrades: Neutral | 314 314 | 293.57 | 6.96% | 2 | Apr 21, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Sector Perform | 30 31 | 20.09 | 54.31% | 3 | Apr 2, 2025 | |
TVTX Travere Therapeutics | Maintains: Strong Buy | 29 31 | 20.81 | 48.97% | 9 | Apr 1, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Sector Outperform | 338 342 | 255.12 | 34.05% | 5 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 30 34 | 14.01 | 142.68% | 5 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Sector Outperform | 40 | 19.91 | 100.9% | 5 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 51 52 | 7.88 | 559.9% | 4 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 73 75 | 49.68 | 50.97% | 4 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 6 4 | 1.42 | 181.69% | 2 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Perform | 433 450 | 498.44 | -9.72% | 5 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 44 41 | 14.58 | 181.21% | 5 | Jan 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 53 75 | 31.03 | 141.7% | 4 | Dec 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 60 | 23.7 | 153.16% | 1 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 18 | 7.12 | 152.81% | 1 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 22 | 8.55 | 157.31% | 1 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 13 15 | 1.62 | 825.93% | 3 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 89 91 | 8.66 | 950.81% | 2 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 9.88 | 21.46% | 3 | May 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 5 2 | 0.74 | 102.7% | 1 | Apr 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 39 | 14.95 | 160.87% | 1 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 | 7.01 | -57.2% | 1 | Nov 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 3.34 | 1995.81% | 1 | Sep 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 20 | n/a | n/a | 2 | Sep 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 8 | 29.38 | -72.77% | 1 | Jun 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Jun 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 25 7 | n/a | n/a | 4 | May 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 54 | 18.55 | 191.11% | 1 | Mar 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 6 | 0.78 | 669.23% | 2 | Mar 14, 2022 |